This document provides an overview of imaging modalities and clinical trial experience for a range of oncology and other indications. It lists the number of studies conducted, patients enrolled, and imaging modalities used for various cancer types in Phases I-IV trials. Additionally, it summarizes immunotherapy clinical trial experience for several cancer indications, including numbers of sites and subjects involved as well as endpoints and criteria.